产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 |
CAS No. |
6042-32-6 |
|---|---|
中文名称 |
2-((R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-羟基-10,13-二甲基十六氢-1H-环戊基并[a]菲-17-基)戊酰胺)乙磺酸钠盐 |
英文名称 |
2-((R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-Hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonic acid, sodium salt |
别名 |
5beta-Cholanic acid-3alpha-ol N-(2-sulphoethyl)-amide sodium salt | Sodium taurolithocholate | DTXSID701036211 | AC-34552 | AKOS025290390 | CS-0101420 | Taurolithocholic acid sodium salt | Taurolithocholic Acid (Sodium Salt) | HY-113308A |
标准英文名 |
sodium 2-((R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonate |
MDL No. |
MFCD00036746 |
分子式 |
C26H44NNaO5S |
分子量 |
505.70 |
精确分子量 |
505.28 |
SMILES |
C[C@@H]([C@H]1CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)CCC(NCCS(=O)([O-])=O)=O.[Na+] |
标准SMILES |
[Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C |
性状 |
White to off-white powder |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
YAERYJYXPRIDTO-HRHHVWJRSA-M |
危险类别(旧) |
H302 |
存储要求 |
Inert atmosphere, Room Temperature,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral,Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory system (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|